AngioDynamics Inc
F:UG2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AngioDynamics Inc
F:UG2
|
US |
|
T
|
Trinity Biotech PLC
F:TRBA
|
IE |
|
C
|
Consolidated Water Co Ltd
F:CW2
|
KY |
|
Z
|
Zip Co Ltd
ASX:ZIP
|
AU |
Wall St Price Targets
UG2 Price Targets Summary
AngioDynamics Inc
According to Wall Street analysts, the average 1-year price target for UG2 is 14.71 EUR with a low forecast of 12.49 EUR and a high forecast of 19.47 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UG2's stock price target?
Price Target
14.71
EUR
According to Wall Street analysts, the average 1-year price target for UG2 is 14.71 EUR with a low forecast of 12.49 EUR and a high forecast of 19.47 EUR.
What is the Revenue forecast for AngioDynamics Inc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 7%.
What is the Gross Profit forecast for AngioDynamics Inc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 5 years is 7%.
